Skip to main content

Table 3 Clinical Outcomes

From: Does intravascular ultrasound provide clinical benefits for percutaneous coronary intervention with bare-metal stent implantation? A meta-analysis of randomized controlled trials

Study

DIPOL

AVID

RESIST

TULIP

OPTICUS

Total

 

IVUS

QCA

IVUS

QCA

IVUS

QCA

IVUS

QCA

IVUS

QCA

IVUS

QCA

Patients, n

83

80

369

375

79

76

73

71

273

275

877

877

Death, n (%)

1 (1.2)

1 (1.3)

12 (3.3)

7 (1.9)

1 (1.3)

1 (1.3)

2 (2.7)

1 (1.4)

5 (1.8)

1 (0.36)

21 (2.4)

11 (1.3)

Nonfatal MI, n (%)

1 (1.2)

4 (5)

25 (6.8)

19 (5.1)

N/A

N/A

1 (1.4)

5 (7.0)

6 (2.2)

10 (3.6)

33 (4.1) 1

38 (4.7) 1

MACE, n (%)

6 (7.2)

13 (16.2)

68 (18.4)

70 (18.7)

20 (25.3)

28 (36.8)

9 (12.3)

19 (26.8)

49 (17.9)

42 (15.3)

152 (17.3)

172 (19.6)

  1. *The analysis of nonfatal MI excludes the RESIST Study, where this outcome was not calculated. MI, myocardial infarction; MACE, major adverse cardiovascular events; IVUS, interventional ultrasound.